Sat, 31 Oct 2026
07:13:27 pm
Rudransh Sangwan
Published at: September 16, 2026, 9:13 AM
Synopsis
ESDS Software Solution shares hit the lower circuit amid profit booking after a strong post-listing rally. Check the latest stock performance and key levels.

ESDS Software Solution shares fell 5% on Wednesday, September 16, hitting the lower circuit amid profit booking. The stock touched Rs 1,733.50 on the NSE, its lowest permissible level for the session.
Despite the fall, ESDS shares remained sharply higher than their listing price of Rs 757. The stock was still up 129.07% from its NSE listing price.
The ESDS share price was down 5% from the previous close, with the stock touching a day high of Rs 1,820 and a low of Rs 1,733.50.
The stock has seen strong buying since its market debut earlier this month. ESDS shares listed at Rs 757 on the NSE, a 76.46% premium over the IPO price of Rs 429.
{{CHART}}
| Stock metric | Value |
|---|---|
| Current price | Rs 1,733.50 |
| Intraday change | Down 5% |
| Day high | Rs 1,820 |
| Day low | Rs 1,733.50 |
| NSE volume | 17.21 lakh shares |
| IPO price | Rs 429 |
| NSE listing price | Rs 757 |
| Gain from listing price | 129.07% |
ESDS Software Solution had raised Rs 720 crore through its IPO, which was priced between Rs 408 and Rs 429 per share. The shares were listed on September 4 on NSE and BSE.
ESDS Software Solution provides AI enabled cloud services, managed services, data centre infrastructure and software solutions. The company serves customers across areas including banking, financial services and government institutions.
The company serves customers across areas including banking, financial services and government institutions.
Loading chart...

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
No related topics available

Motilal Oswal Q2 FY27 results show net profit rising 198% to ₹1,080 crore, revenue increasing 64% to ₹3,040 crore and EBITDA margin reaching 60.37%.

Bliss GVS Pharma Q2 FY27 results show revenue rising 37.3% to ₹261.13 crore, EBITDA jumping 161.4% and net profit increasing 196%.

Alivus Life Sciences Q2 FY27 results show net profit rising 51.3% to ₹196.8 crore, revenue growing 16% to ₹682 crore and EBITDA margin reaching 38.

Thyrocare Q2 FY27 revenue rose 25.1% to ₹270.81 crore, while net profit fell 66.9% to ₹15.89 crore amid a ₹44.98 crore impairment loss.

Patel Retail will invest ₹2 crore to add 20,000 sq ft to its Ambernath distribution centre, increasing covered area to 84,000 sq ft.